关键词
ACC/AHA Clinical Practice Guidelines,focused update,acute coronary syndrome,anticoagulants,anticoagulation agents,antiplatelet agents,apixaban,atrial fibrillation,atrial flutter,cardioversion,coronary artery disease,coronary heart disease,stents,dabigatran,edoxaban,hypertension,idarucizumab,myocardial infarction,obesity,percutaneous coronary intervention,risk factors,rivaroxaban,sleep apnea,stroke,thromboembolism,warfarin